Prognostic utility of linear segmentation in nonmetastatic renal cell carcinoma: Correlation of overall survival with muscle mass.

Authors

null

Benjamin Schmeusser

Department of Urology, Emory University School of Medicine, Atlanta, GA

Benjamin Schmeusser , Eric Midenberg , Arnold Raul Palacios , Nikhil Vettikattu , Dattatraya H Patil , Reza Nabavizadeh , Alexandra Medline , Michelle Higgins , Sarah P. Psutka , Kenneth Ogan , Viraj A. Master

Organizations

Department of Urology, Emory University School of Medicine, Atlanta, GA, Department of Urology, Creighton University School of Medicine, Omaha, NE, Emory University School of Medicine, Atlanta, GA, Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, Emory University, Atlanta, GA

Research Funding

Other Foundation
John Robinson Family Foundation and Chris Churchill Family Foundation

Background: In renal cell carcinoma (RCC) and other solid organ malignancies, sarcopenia has been associated with decreased survival and increased perioperative complications. Traditional body composition analysis is an expensive and time extensive process. As a modifiable risk factor, more clinic friendly methods to identify patients with low muscle composition is of interest. Linear segmentation on routine imaging has been proposed as a fast, reliable and reproducible alternative. This study assesses the prognostic ability of linear segmentation in patients with nonmetastatic RCC. Methods: Patients that underwent nephrectomy for nonmetastatic RCC from 2005-2021 at an academic referral center were identified. Linear segmentation of the bilateral psoas/paraspinal muscles was completed on preoperative imaging obtained within 60 days of surgery. Cox proportional-hazards analysis was used to determine association between total muscle index and overall survival. Results: 532 (388 clear cell) patients were analyzed and a median total muscle index was 28.6 (25.8-32.5) for women and 33.3 (29.1-36.9) for men. As a binary variable, lower total muscle index was significantly associated with decreased survival in both the full (HR=1.96, 95% CI 1.32-2.90, p<0.001) and clear cell only cohorts (HR=1.78, 95% CI 1.08-2.75, p=0.022). As a continuous variable, unit increases in total muscle index were significantly associated with improved survival in the full cohort (HR=0.95, 95% CI 0.92-0.99, p=0.006) and the clear cell only cohort (HR=0.95, 95% CI 0.92-0.99, p=0.016). Conclusions: Assessment of muscle composition via linear segmentation on routinely obtained preoperative imaging is a clinically feasible technique with prognostic utility in patients with localized RCC. In this cohort of patients with nonmetastatic RCC, linear segmentation demonstrated significant associations with overall survival as a binary and continuous variable. This simplified technique may allow for routine inclusion of body composition into clinical decision making.

Cox proportional-hazards analysis for association of total muscle index measured by linear segmentation with overall survival in nonmetastatic renal cell carcinoma (n=532).
CovariateHazard Ratio (95% CI)HR P-value
Below Median Total Muscle Index1.96 (1.32-2.90)<0.001
Continuous Total Muscle Index0.95 (0.92-0.99)0.006

*Total Muscle Index=[Total Muscle Area]/height (m2). Other variables in model include age 60+, gender, race, obesity, ECOG, Nephrectomy type, T-Stage, N-Stage, grade, and histology.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Diagnostics and Imaging

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 617)

DOI

10.1200/JCO.2023.41.6_suppl.617

Abstract #

617

Poster Bd #

E7

Abstract Disclosures

Similar Abstracts

First Author: Lisa Joy Centeno

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Association of intensifying supportive care with improved survival in patients with gastric cancer with malignant ascites.

First Author: John D Karalis